NCI to Fund Small Businesses Developing Molecular Analysis Tools | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund small businesses undertaking projects to develop new molecular or cellular analysis tools for use in cancer research and clinical care, according to a new funding announcement.

These Small Business Innovation Research grants will fund R&D projects under NCI's Innovative Molecular Analysis Technology (IMAT) program, which supports early-stage development and validation of high-risk, high-payoff tools that improve the molecular or cellular analysis of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.